Associated Papers
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
Martinez Rodriguez A et al.
British Journal of Haematology, 2026
Coexistence of VEXAS Syndrome and Chronic Hepatitis B Virus Infection: a Case Report and Literature Review.
Lin K et al.
Clinical Reviews in Allergy & Immunology, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
Wadsworth PA et al.
American Journal of Clinical Pathology, 2025
From diagnostic uncertainty to targeted therapy: a case-based review of VEXAS syndrome.
Rana G et al.
Rheumatology International, 2025
Ocular Features of VEXAS Syndrome: A Systematic Review and Meta-analysis.
Quigley C et al.
American Journal of Ophthalmology, 2025
Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.
Fiumara M et al.
Expert Review of Hematology, 2025
Kidney involvement in VEXAS syndrome: insights from a rare case of secondary amyloidosis and systematic review of renal biopsy-confirmed reports.
Ştefan G et al.
Clinical Rheumatology, 2025
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.
Kirino Y et al.
Rheumatology (oxford, England), 2025
Rapid Screening and Monitoring of UBA1 Mutations in VEXAS Syndrome.
Martín Castillo I et al.
The Journal of Molecular Diagnostics : Jmd, 2025
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder - A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape.
Singh A et al.
Journal of Autoimmunity, 2025
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome.
Mizumaki H et al.
Nature Communications, 2025
Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment.
Johansen MM et al.
Rheumatology (oxford, England), 2025
Neurological manifestations in patients with VEXAS syndrome.
Bert-Marcaz C et al.
Journal of Neurology, 2025
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management.
Costa A et al.
Annals of Hematology, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network.
Vitale A et al.
Frontiers in Pharmacology, 2025
Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature.
Alnahas Z et al.
Open Access Rheumatology : Research and Reviews, 2025
VEXAS: A review of current understandings and emerging treatment strategies.
Holden R et al.
Frontiers in Immunology, 2025
Case Report: VEXAS syndrome with extensive pulmonary, cardiac, and skeletal involvement.
Fang Z et al.
Frontiers in Immunology, 2025
VEXAS syndrome in rheumatology practice: features from a multicenter cohort in north-east Italy.
Bindoli S et al.
Frontiers in Immunology, 2025
Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patients.
Ali SB et al.
Clinical Rheumatology, 2024
De-escalation of corticosteroids and clonal remission in UBA1 mutation-driven VEXAS syndrome with 5-azacytidine.
Trikha R et al.
Haematologica, 2024
The Histopathology of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic Syndrome: Report of 12 Skin Biopsies From 6 Patients.
Brumbaugh BJ et al.
The American Journal of Dermatopathology, 2024
Navigating therapeutic challenges in VEXAS syndrome: exploring IL-6 and JAK inhibitors at the forefront.
Li XX et al.
Molecular Medicine (cambridge, Mass.), 2024
A clinical phenotype of VEXAS syndrome with pleural effusion, infiltrates, and systemic inflammation in a 76-year-old patient: a case report.
Berger M et al.
Journal of Medical Case Reports, 2024
Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome.
Maeda A et al.
Rheumatology (oxford, England), 2024
Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome.
Lecoeuvre H et al.
Clinical and Experimental Dermatology, 2024
How I diagnose and manage VEXAS syndrome.
Hagiya A et al.
American Journal of Clinical Pathology, 2024
Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
Kouranloo K et al.
Rheumatology International, 2024
VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease.
Philip R et al.
Joint Bone Spine, 2024
Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients.
Olteanu H et al.
American Journal of Clinical Pathology, 2024
VEXAS syndrome: a Swiss national retrospective cohort study.
Wolff L et al.
Swiss Medical Weekly, 2024
VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
Saad AJ et al.
Experimental Dermatology, 2024
A novel XNA-based Luminex assay to detect UBA1 somatic mutations associated with VEXAS syndrome.
Ma Y et al.
Practical Laboratory Medicine, 2024
VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
Koster MJ et al.
American Journal of Hematology, 2024
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Gurnari C et al.
American Journal of Hematology, 2024
Dynamic monitoring of UBA1 somatic mutations in patients with relapsing polychondritis.
Duan S et al.
Orphanet Journal of Rare Diseases, 2024
VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.
Loeza-Uribe MP et al.
Reumatologia Clinica, 2024
Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome.
Adachi S et al.
Rheumatology Advances in Practice, 2024
Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis.
Baggio C et al.
Frontiers in Immunology, 2024
Long-term remission of VEXAS syndrome achieved by a single course of CHOP therapy: A case report.
Miyoshi Y et al.
Modern Rheumatology Case Reports, 2023
Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndrome.
Hines AS et al.
Rheumatology (oxford, England), 2023
Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism.
Mascaro JM et al.
Annals of the Rheumatic Diseases, 2023
VEXAS-Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations.
Baur V et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg, 2023
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
Kunimoto H et al.
International Journal of Hematology, 2023
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
Mangaonkar AA et al.
American Journal of Hematology, 2023